Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...

The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...

Companies, 23andMe included, also have a responsibility to notify consumers of changes and get "consumers' affirmative ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

A company representative shows off what is in a DNA kit at the 23andMe booth at the RootsTech annual genealogical event in ...

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. 23andMe said Monday it will lay off ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a ...

Anne Wojcicki; Chairman of the Board, President, Chief Executive Officer, Co-Founder; 23andMe Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer; 23andMe Holding ...